VisageX Medical

Non-invasive post-surgical Adjustable Facial Implants for Reconstructive and Aesthetics Surgery

Health Tech & Life Sciences
Stealth Mode
Pre-Seed Israel Founded 2022
Last updated 2026-06-18
Total raised
$1.4M
Last: Grant 2024-07
Stage
Pre-Seed
Founded
2022
Headcount
4
HQ
Israel
Sector
Health Tech & Life Sciences

About

VisageX is creating a new category in medical implants – Adjustable Permanent Implants (API) – smart, programmable implants that can be reshaped after implantation using safe, non-invasive induction heating of shape memory materials.

Our vision is to build a platform of adjustable implants that can be tailored to a variety of clinical applications, including reconstructive, aesthetic, cranial, orthopedic, urological, and ENT indications. This vision begins with our first generation of facial reconstructive implants, addressing clear unmet needs in craniomaxillofacial (CMF) surgery, where current implants are static and revisions are common.

We have started our First-in-Human (FIH) study with early promising results.

Our mission: To become the recognized leader for Adjustable Implants tailored to each patient’s individual needs and expectations.

Funding history · 4 rounds · $1.4M total

2024-07
Grant $275K
2024-07
$290K
2022-03
Grant $750K
2022-03

Q&A

What is VisageX Medical's primary business?
VisageX Medical specializes in non-invasive post-surgical adjustable facial implants for reconstructive and aesthetic surgery, creating a new category of Adjustable Permanent Implants (API).
When was VisageX Medical founded?
VisageX Medical was founded in March 2022.
What is the current employee count for VisageX Medical?
VisageX Medical has 1-10 employees.
What is VisageX Medical's total funding to date?
VisageX Medical has raised a total of $1,445,000 across multiple funding rounds.
When was VisageX Medical's most recent funding round?
VisageX Medical's most recent funding round was a Grant in July 2024, which raised $275,000.
Which investor participated in VisageX Medical's initial funding round in March 2022?
The Trendlines Group participated in VisageX Medical's funding round in March 2022.
What is the product stage of VisageX Medical?
VisageX Medical's product is currently in the clinical trial stage, having started its First-in-Human (FIH) study.
Who is the Co-founder and CEO of VisageX Medical?
Gideon Meyer Brodnitz is the Co-founder and CEO of VisageX Medical.

Team · 1

Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
ComponentsModularFixedMaterials & SubstancesAlloysImplantsCompositesPolymersSilicon
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2BB2C

Highlights

1 PatentsVerified

Tags

doctorssurgerysiliconemedical-devicesneurosurgerysurgeonsstealthmodehospitals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

WebsiteVisageX.com
LinkedInlinkedin.com/company/88063104

Identifiers & details

Founded2022-3
Employees (exact)4
OfficesKarmiel

Radar intelligence

Patents

EPO2

Web history (Wayback)

DomainVisageX.com

Certificate / subdomain footprint

Subdomains0